Causes and consequences of micronuclei

Ksenia Krupina1, Alexander Goginashvili1, Don W Cleveland1

  • 1Ludwig Institute for Cancer Research, University of California at San Diego, La Jolla, CA, 92093, USA; Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA, 92093, USA.

Insights

Micronuclei, small nuclear compartments, are linked to genome instability and cancer. This review discusses their formation, consequences like DNA damage, and protective cellular mechanisms against micronucleation.

Area of Science:

  • Cell Biology
  • Genetics
  • Cancer Research

Background:

  • Micronuclei are nuclear-like structures containing DNA, spatially distinct from the main nucleus.
  • They are associated with chromosome instability, genome rearrangements, and mutagenesis.
  • Micronuclei are observed in various conditions, including cancer, senescence, and following genotoxic stress.

Purpose of the Study:

  • To review recent findings on micronuclei generation.
  • To discuss the consequences of micronuclei formation, including DNA damage and cellular responses.
  • To explore cellular mechanisms that protect against micronucleation.

Main Methods:

  • Literature review of recent findings on micronuclei.
  • Analysis of the role of micronuclei in genome instability and cancer.
  • Discussion of cellular mechanisms involved in micronucleation and its prevention.

Main Results:

  • Micronuclear envelope compromise disrupts DNA replication and repair, exposing DNA to the cytoplasm.
  • Micronuclear DNA can lead to complex genome rearrangements, such as chromothripsis.
  • Micronuclei can trigger a cyclic GMP-AMP synthase (cGAS)-mediated immune response, potentially promoting cancer metastasis.

Conclusions:

  • Micronuclei are critical players in tumorigenesis and cancer progression.
  • Understanding micronuclei formation and consequences is vital for developing cancer therapies.
  • Cellular mechanisms protecting against micronucleation are important targets for intervention.

Related Concept Videos

Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
4.4K
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
39.7K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
41.9K
Mutations01:39

Mutations

Overview
91.1K
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
756
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.7K